ARCHIVES

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

NY Attorney General Subpoenaes Amgen, J&J Over ESA Promotion.

May 25, 2007

In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million

October 31, 1980

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984

Garb’s Questions, Answers About Cancer Program

December 5, 1980